Detection and interpretation of altered methylation patterns in cancer cells (original) (raw)

• Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415–428 (2002).
  Article CAS PubMed Google Scholar
• Ohlsson, R., Renkawitz, R. & Lobanenkov, V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. 17, 520–527 (2001).
  Article CAS PubMed Google Scholar
• Hark, A. T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405, 486–489 (2000).
  Article CAS PubMed Google Scholar
• Bell, A. C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482–485 (2000).
  Article CAS PubMed Google Scholar
• Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genet. 33 (Suppl.), 245–254 (2003).
  Article CAS PubMed Google Scholar
• Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457–463 (2004).
  Article CAS PubMed Google Scholar
• Takai, D. & Jones, P. A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA 99, 3740–3745 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• De Smet, C., Lurquin, C., Lethe, B., Martelange, V. & Boon, T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327–7335 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Futscher, B. W. et al. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genet. 31, 175–179 (2002).
  Article CAS PubMed Google Scholar
• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  Article CAS PubMed Google Scholar
• Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983).
  Article CAS PubMed Google Scholar
• Kaneda, A. et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci. 95, 58–64 (2004).
  Article CAS PubMed Google Scholar
• Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L. & Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89–93 (1998).
  Article CAS PubMed Google Scholar
• Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489–492 (2003).
  Article CAS PubMed Google Scholar
• Kanai, Y. et al. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn J. Cancer Res. 87, 1210–1217 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshikawa, H. et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nature Genet. 28, 29–35 (2001).
  CAS PubMed Google Scholar
• Suzuki, H. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nature Genet. 36, 417–422 (2004).
  Article CAS PubMed Google Scholar
• Kaneda, A. et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res. 64, 6410–6415 (2004).
  Article CAS PubMed Google Scholar
• Esteller, M. et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59, 67–70 (1999).
  CAS PubMed Google Scholar
• Wong, I. H. et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59, 71–73 (1999).
  CAS PubMed Google Scholar
• Laird, P. W. The power and the promise of DNA methylation markers. Nature Rev. Cancer 3, 253–266 (2003).
  Article CAS Google Scholar
• Belinsky, S. A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nature Rev. Cancer 4, 707–717 (2004).
  Article CAS Google Scholar
• Ohgane, J., Hattori, N., Oda, M., Tanaka, S. & Shiota, K. Differentiation of trophoblast lineage is associated with DNA methylation and demethylation. Biochem. Biophys Res. Commun. 290, 701–706 (2002).
  Article CAS PubMed Google Scholar
• Kaneda, A., Kaminishi, M., Yanagihara, K., Sugimura, T. & Ushijima, T. Identification of silencing of nine genes in human gastric cancers. Cancer Res. 62, 6645–6650 (2002).
  PubMed Google Scholar
• Hayatsu, H., Wataya, Y., Kai, K. & Iida, S. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry 9, 2858–2865 (1970).
  Article CAS PubMed Google Scholar
• Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H. & Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl Acad. Sci. USA. 88, 9523–9527 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Lisitsyn, N., Lisitsyn, N. & Wigler, M. Cloning the differences between two complex genomes. Science 259, 946–951 (1993).
  Article CAS PubMed Google Scholar
• Welsh, J., Petersen, C. & McClelland, M. Polymorphisms generated by arbitrarily primed PCR in the mouse: application to strain identification and genetic mapping. Nucleic Acids Res. 19, 303–306 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Kawai, J. et al. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res. 21, 5604–5608 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Wimmer, K. et al. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosom. Cancer 33, 285–294 (2002).
  Article CAS PubMed Google Scholar
• Ushijima, T. et al. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc. Natl Acad. Sci. USA 94, 2284–2289 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kaneda, A., Takai, D., Kaminishi, M., Okochi, E. & Ushijima, T. Methylation-sensitive representational difference analysis and its application to cancer research. Ann. NY Acad. Sci. 983, 131–141 (2003).
  Article CAS PubMed Google Scholar
• Gonzalgo, M. L. et al. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594–599 (1997).
  CAS PubMed Google Scholar
• Huang, T. H. et al. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57, 1030–1034 (1997).
  CAS PubMed Google Scholar
• Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307–2312 (1999).
  CAS PubMed Google Scholar
• Huang, T. H., Perry, M. R. & Laux, D. E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8, 459–470 (1999).
  Article CAS PubMed Google Scholar
• Yan, P. S. et al. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin. Cancer Res. 6, 1432–1438 (2000).
  CAS PubMed Google Scholar
• Shi, H. et al. Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res. 62, 3214–3220 (2002).
  CAS PubMed Google Scholar
• Shi, H. et al. Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res. 63, 2164–2171 (2003).
  CAS PubMed Google Scholar
• Adorjan, P. et al. Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res. 30, e21 (2002).
  Article PubMed PubMed Central Google Scholar
• Novik, K. L. et al. Epigenomics: genome-wide study of methylation phenomena. Curr. Issues Mol. Biol. 4, 111–128 (2002).
  CAS PubMed Google Scholar
• Gitan, R. S., Shi, H., Chen, C. M., Yan, P. S. & Huang, T. H. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res. 12, 158–164 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ballestar, E. et al. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22, 6335–6345 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kondo, Y., Shen, L., Yan, P. S., Huang, T. H. & Issa, J. P. Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Proc. Natl Acad. Sci. USA 101, 7398–7403 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature Genet. 31, 141–149 (2002).
  Article CAS PubMed Google Scholar
• Gonzalgo, M. L. et al. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res. 58, 1245–1252 (1998).
  CAS PubMed Google Scholar
• Abe, M. et al. Cloning of the 5′ upstream region of the rat p16 gene and its role in silencing. Jpn J. Cancer Res. 93, 1100–1106 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Deng, G., Chen, A., Hong, J., Chae, H. S. & Kim, Y. S. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 59, 2029–2033 (1999).
  CAS PubMed Google Scholar
• Miyakura, Y. et al. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 121, 1300–1309 (2001).
  Article CAS PubMed Google Scholar
• Yan, P. S. et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res. 63, 6178–6186 (2003).
  CAS PubMed Google Scholar
• Hagihara, A. et al. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 23, 8705–8710 (2004).
  Article CAS PubMed Google Scholar
• Issa, J. P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genetics 7, 536–540 (1994).
  Article CAS PubMed Google Scholar
• Ahuja, N., Li, Q., Mohan, A. L., Baylin, S. B. & Issa, J. P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 58, 5489–5494 (1998).
  CAS PubMed Google Scholar
• Issa, J. P., Ahuja, N., Toyota, M., Bronner, M. P. & Brentnall, T. A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 61, 3573–3577 (2001).
  CAS PubMed Google Scholar
• Waki, T., Tamura, G., Sato, M. & Motoyama, T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22, 4128–4133 (2003).
  Article CAS PubMed Google Scholar
• Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B. & Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem. 272, 22322–22329 (1997).
  Article CAS PubMed Google Scholar
• Song, J. Z., Stirzaker, C., Harrison, J., Melki, J. R. & Clark, S. J. Hypermethylation trigger of the glutathione-_S_-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21, 1048–1061 (2002).
  Article CAS PubMed Google Scholar
• Stirzaker, C., Song, J. Z., Davidson, B. & Clark, S. J. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64, 3871–3877 (2004).
  Article CAS PubMed Google Scholar
• De Smet, C., Loriot, A. & Boon, T. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol. Cell. Biol. 24, 4781–4790 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ushijima, T. et al. Decreased fidelity in replicating CpG methylation patterns in cancer cells. Cancer Res. 65, 11–17 (2005).
  CAS PubMed Google Scholar
• Nguyen, C. et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J. Natl Cancer Inst. 93, 1465–1472 (2001).
  Article CAS PubMed Google Scholar
• Ushijima, T. et al. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 13, 868–874 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kaneda, A., Kaminishi, M., Nakanishi, Y., Sugimura, T. & Ushijima, T. Reduced expression of the insulin-induced protein 1 and p41 Arp2/3 complex genes in human gastric cancers. Int. J. Cancer 100, 57–62 (2002).
  Article CAS PubMed Google Scholar
• Bender, C. M. et al. Roles of cell division and gene transcription in the methylation of CpG islands. Mol. Cell. Biol. 19, 6690–6698 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Abe, M. et al. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res. (in the press).
• Li, H. et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl Acad. Sci. USA 100, 8412–8417 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Dai, Z. et al. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene 23, 3521–3529 (2004).
  Article CAS PubMed Google Scholar
• Costello, J. F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet. 24, 132–138 (2000).
  Article CAS PubMed Google Scholar
• Takai, D. et al. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene 20, 7505–7513 (2001).
  Article CAS PubMed Google Scholar
• Asada, K. et al. Reduced expression of GNA11 and silencing of MCT1 in human breast cancers. Oncology 64, 380–388 (2003).
  Article CAS PubMed Google Scholar
• Miyamoto, K. et al. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 22, 274–280 (2003).
  Article CAS PubMed Google Scholar
• Palmisano, W. A. et al. Aberrant promoter methylation of the transcription factor genes PAX5α and β in human cancers. Cancer Res. 63, 4620–4625 (2003).
  CAS PubMed Google Scholar
• Toyota, M., Ho, C., Ohe-Toyota, M., Baylin, S. B. & Issa, J. P. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res. 59, 4535–4541 (1999).
  CAS PubMed Google Scholar
• Sato, N. et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 63, 3735–3742 (2003).
  CAS PubMed Google Scholar
• Kawakami, T., Okamoto, K., Ogawa, O. & Okada, Y. _XIST_unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. Lancet 363, 40–42 (2004).
  Article CAS PubMed Google Scholar
• Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. & Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93, 9821–9826 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Liang, G. et al. DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics 53, 260–268 (1998).
  Article CAS PubMed Google Scholar
• Esteller, M. et al. Hypermethylation of the DNA repair gene _O_6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J. Natl Cancer Inst. 94, 26–32 (2002).
  Article CAS PubMed Google Scholar
• Esteller, M. et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 343, 1350–1354 (2000).
  Article CAS PubMed Google Scholar
• Esteller, M. & Herman, J. G. Generating mutations but providing chemosensitivity: the role of _O_6-methylguanine DNA methyltransferase in human cancer. Oncogene 23, 1–8 (2004).
  Article CAS PubMed Google Scholar
• Tada, Y. et al. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Cancer Res. 62, 4048–4053 (2002).
  CAS PubMed Google Scholar
• Chan, A. O. et al. CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. 160, 1823–1830 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Waki, T. et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am. J. Pathol. 161, 399–403 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, H. et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753–1755 (2003).
  Article CAS PubMed Google Scholar
• Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681–8686 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, M. A. et al. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12, 2507–2513 (1996).
  CAS PubMed Google Scholar
• Tsuchiya, T. et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19, 3642–3646 (2000).
  Article CAS PubMed Google Scholar
• Li, W. -H., Gu, Z., Wang, H. & Nekrutenko, A. Evolutionary analyses of the human genome. Nature 409, 847–849 (2001).
  Article CAS PubMed Google Scholar
• Gardiner-Garden, M. & Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261–282 (1987).
  Article CAS PubMed Google Scholar
• Muller, H. M. et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 63, 7641–7645 (2003).
  PubMed Google Scholar